Review Article

Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature

Table 4

CASP quality assessment checklist of included clinical trials using the CASP checklist for randomised controlled trials.

First author, yearSection ASection BSection C
1234567891011

Rayes, 2002 [82]YesYesYesYesYesNoSmallPartialYesYesYes
Kanazawa, 2005 [83]YesYescannot tellcannot tellYesYesSomePartialYesYesYes
Rayes, 2005 [84]YesYesYesYesYesYesSmallPartialYesYesYes
Sugawara 2006 [56]YesYesYescannot tellYesNANAPartialYesNoYes
Rayes, 2007 [85]YesYesYesYesYesYesSmallPartialYesYesYes
Peral, 2009 [22]Yescannot tellYescannot tellYescannot tellLargePartialYesYesYes
Peral, 2010 [86]YesNoYesNoNoNANAPartialYesNoYes
Liu, 2011 [87]YesYesYesYesYesYesSomePreciseYesYesYes
Usami, 2011 [88]YesYesYescannot tellYesYesSmallNot preciseYesYesYes
Zhang, 2012 [89]YesYescannot tellYesYesYesSomePreciseYesYesYes
Zhang, 2013 [90]Yescannot tellYescannot tellYesYesSomePartialYesYesYes
Sadahiro, 2014 [57]YesYesYescannot tellYesYesSomePreciseYesYesYes
Aisu, 2015 [91]YesNocannot tellNoYesYesSomePreciseYesYesYes
Kotzampassi, 2015 [58]YesYesYesYesYesYesSomePreciseYesYesYes
Mayes, 2015 [92]YesYesYescannot tellYesYesSomePreciseYesYesYes
El-Ghazely, 2016 [93]YesYesYesYesYesYesSomePreciseYesYesYes
Kotmatsu, 2016 [94]YesYesYesNoNoYesSomePreciseYesYesYes
Yang, 2016 [95]YesYesYesYesYesYesSmallPreciseYesYesYes

1. Does the trial address a clearly focused issue? 2. Was the assignment of patients to treatments randomized? 3. Were all the patients who entered the trial properly accounted for at its conclusion? Were patients, health workers and study personnel “blind” to treatment? 5. Were the groups similar at the start of the trial? 6. Aside from the experimental intervention, where the groups treated equally? 7. How large was the treatment effect? 8. How precise was the estimate of the treatment effect? 9. Can the results be applied to local population, or in your context? 10. Were all clinically important outcomes considered? 11. Are the benefits worth the harms and costs? NA-not applicable, because was no control group.